HK1153834A1 - Lung cancer biomarkers and uses thereof - Google Patents

Lung cancer biomarkers and uses thereof

Info

Publication number
HK1153834A1
HK1153834A1 HK11107896.7A HK11107896A HK1153834A1 HK 1153834 A1 HK1153834 A1 HK 1153834A1 HK 11107896 A HK11107896 A HK 11107896A HK 1153834 A1 HK1153834 A1 HK 1153834A1
Authority
HK
Hong Kong
Prior art keywords
lung cancer
cancer biomarkers
biomarkers
lung
cancer
Prior art date
Application number
HK11107896.7A
Other languages
English (en)
Chinese (zh)
Inventor
Larry Gold
Marty Stanton
Edward N Brody
Rachel M Ostroff
Dominic Zichi
Alex A E Stewart
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of HK1153834A1 publication Critical patent/HK1153834A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10Complex mathematical operations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Mathematical Physics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • Pure & Applied Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • Algebra (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Computational Mathematics (AREA)
  • Software Systems (AREA)
  • Mathematical Analysis (AREA)
HK11107896.7A 2008-09-09 2011-07-29 Lung cancer biomarkers and uses thereof HK1153834A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9559308P 2008-09-09 2008-09-09
US15283709P 2009-02-16 2009-02-16
PCT/US2009/056399 WO2010030697A1 (en) 2008-09-09 2009-09-09 Lung cancer biomarkers and uses thereof

Publications (1)

Publication Number Publication Date
HK1153834A1 true HK1153834A1 (en) 2012-04-05

Family

ID=42005456

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11107896.7A HK1153834A1 (en) 2008-09-09 2011-07-29 Lung cancer biomarkers and uses thereof
HK15104677.5A HK1204062A1 (en) 2008-09-09 2015-05-18 Lung cancer biomarkers and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15104677.5A HK1204062A1 (en) 2008-09-09 2015-05-18 Lung cancer biomarkers and uses thereof

Country Status (14)

Country Link
EP (1) EP2340506B1 (xx)
JP (1) JP5701212B2 (xx)
KR (1) KR101658347B1 (xx)
CN (2) CN104198709A (xx)
AU (2) AU2009291811B2 (xx)
CA (3) CA3011730C (xx)
DK (1) DK2340506T3 (xx)
ES (1) ES2559758T3 (xx)
GB (1) GB2478441B (xx)
HK (2) HK1153834A1 (xx)
HR (1) HRP20160127T1 (xx)
MX (1) MX2011002322A (xx)
SI (1) SI2340506T1 (xx)
WO (1) WO2010030697A1 (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
EP3444359A1 (en) 2009-03-12 2019-02-20 Cancer Prevention And Cure, Ltd. Methods of identification of non-small cell lung cancer
AU2011274422B2 (en) * 2010-07-09 2016-02-11 Somalogic Operating Co., Inc. Lung cancer biomarkers and uses thereof
WO2012021795A2 (en) 2010-08-13 2012-02-16 Somalogic, Inc. Pancreatic cancer biomarkers and uses thereof
RU2612017C2 (ru) * 2011-04-07 2017-03-01 Де Скриппс Рисерч Инститьют Высокопроизводительный скрининг соединений, модулирующих экспрессию клеточных макромолекул
EP2702411A4 (en) 2011-04-29 2015-07-22 Cancer Prevention & Cure Ltd METHODS OF IDENTIFYING AND DIAGNOSING PULMONARY DISEASES USING CLASSIFICATION SYSTEMS AND THEIR KITS
KR101921945B1 (ko) * 2011-10-24 2018-11-26 소마로직, 인크. 폐암 바이오마커 및 그것의 용도
US11913957B2 (en) 2011-12-21 2024-02-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
US9201044B2 (en) 2011-12-21 2015-12-01 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US9304137B2 (en) 2011-12-21 2016-04-05 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
BR112014020040A8 (pt) * 2012-02-17 2017-07-11 Koninklijke Philips Nv Meio de armazenamento não transitório que armazena as instruções executáveis por um dispositivo de processamento eletrônico de dados que inclui um visor para o monitoramento de um paciente com lesão pulmonar aguda, aparelho, e, método
CN104812913B (zh) 2012-11-07 2019-03-15 私募蛋白质体公司 慢性阻塞性肺疾病(copd)生物标记及其用途
CA2928271C (en) * 2013-11-07 2022-05-31 Medial Research Ltd. Methods and systems of evaluating a risk of lung cancer
KR102078310B1 (ko) * 2015-09-11 2020-02-19 주식회사 압타머사이언스 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법
FR3050269B1 (fr) 2016-04-15 2018-05-11 Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris (Espci) Procede de selection et de recuperation de produits et systeme associe
CN105823665A (zh) * 2016-05-13 2016-08-03 北京九州柏林生物科技有限公司 生物组织样本制备套液
CN109715830A (zh) 2016-06-21 2019-05-03 威斯塔解剖学和生物学研究所 用于使用基因表达谱诊断肺癌的组合物和方法
JP6280997B1 (ja) * 2016-10-31 2018-02-14 株式会社Preferred Networks 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法
CA3058481A1 (en) 2017-04-04 2018-10-11 Lung Cancer Proteomics, Llc Plasma based protein profiling for early stage lung cancer prognosis
CN111148844A (zh) 2017-09-01 2020-05-12 韦恩生物科技股份公司 鉴定和使用糖肽作为诊断和治疗监测的生物标记物
EP3714275A4 (en) * 2017-11-22 2021-10-27 Gritstone bio, Inc. REDUCTION OF JUNCTION EPITOPIC PRESENTATION FOR NEOANTIGENS
US20210247387A1 (en) * 2018-06-22 2021-08-12 Somalogic, Inc. Improved proteomic multiplex assays
CN114026424A (zh) * 2019-06-21 2022-02-08 新加坡国立大学 用于确定肺癌的可能性的方法
CN110579611B (zh) * 2019-09-18 2023-01-31 郑州大学 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法
CN111047609B (zh) * 2020-03-13 2020-07-24 北京深睿博联科技有限责任公司 肺炎病灶分割方法和装置
CN116381073A (zh) * 2020-10-10 2023-07-04 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 生物标志物在制备肺癌检测试剂中的用途和方法
CN112557514B (zh) * 2020-12-22 2021-09-21 中国海洋大学 手持式海底沉积物样品剖面声学全自动测量装置

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596503B1 (en) * 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
CN1554025A (zh) * 2001-03-12 2004-12-08 Īŵ���ɷ����޹�˾ 患病状态的细胞为基础的检测和鉴别
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
AU2002309583A1 (en) * 2001-04-18 2002-11-05 Protein Desing Labs, Inc. Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
US8014952B2 (en) * 2002-12-18 2011-09-06 Queen Elizabeth Hospital Serum biomarkers in lung cancer
CN1225477C (zh) * 2003-03-28 2005-11-02 上海市疾病预防控制中心 肺癌早期血清特异蛋白及其应用
CN1455257A (zh) * 2003-05-23 2003-11-12 北京师范大学 一种利用表面修饰蛋白芯片进行肺癌诊断方法
TW200600785A (en) * 2004-03-23 2006-01-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancer
JP2005304497A (ja) * 2004-03-25 2005-11-04 Joji Inasawa 特定の癌関連遺伝子を用いる癌の検出方法及び癌の抑制方法
ES2367311T3 (es) * 2004-04-15 2011-11-02 University Of Florida Research Foundation, Inc. Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales.
EP1743031A4 (en) * 2004-04-26 2008-05-28 Childrens Medical Center BLOOD PLATE BIOMARKERS FOR THE DETECTION OF ILLNESSES
US8173433B2 (en) * 2004-08-02 2012-05-08 Vermillion, Inc. Platelet biomarkers for cancer
CN1873417A (zh) * 2005-06-02 2006-12-06 中国医学科学院肿瘤医院肿瘤研究所 一种用于诊断肺癌的蛋白质芯片
US20070178504A1 (en) * 2005-12-22 2007-08-02 Tracey Colpitts Methods and marker combinations for screening for predisposition to lung cancer
US7908091B2 (en) * 2006-03-17 2011-03-15 Prometheus Laboratories Inc. Methods of predicting and monitoring tyrosine kinase inhibitor therapy
AU2007313551A1 (en) * 2006-10-17 2008-04-24 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
WO2008097908A2 (en) * 2007-02-05 2008-08-14 Dana-Farber Cancer Institute, Inc. Methods of diagnosing and prognosing lung cancer
KR100846354B1 (ko) * 2007-03-21 2008-07-15 (주) 프로탄바이오 혈청 당단백질부터 분리한 폐암 진단용 마커
WO2008144512A1 (en) * 2007-05-18 2008-11-27 University Of Southern California Germline polymorphisms in the angiogenic pathway predict tumor recurrence in cancer therapy
US7888051B2 (en) * 2007-09-11 2011-02-15 Cancer Prevention And Cure, Ltd. Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
WO2010003772A1 (en) * 2008-06-16 2010-01-14 Siemens Medical Solutions Diagnostics Gmbh Method for predicting adverse response to erythropoietin in breast cancer treatment
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
KR101824746B1 (ko) * 2010-02-10 2018-02-01 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 폐암 검출용 타액 바이오마커

Also Published As

Publication number Publication date
ES2559758T3 (es) 2016-02-15
AU2015249113B2 (en) 2017-09-07
HRP20160127T1 (hr) 2016-03-11
EP2340506A1 (en) 2011-07-06
GB2478441B (en) 2013-03-27
KR101658347B1 (ko) 2016-09-21
KR20110063753A (ko) 2011-06-14
MX2011002322A (es) 2011-05-10
CA3011730A1 (en) 2010-03-18
CA2734535C (en) 2018-08-28
CN102209968A (zh) 2011-10-05
AU2009291811B2 (en) 2015-10-29
EP2340506A4 (en) 2012-02-15
EP2340506B1 (en) 2015-11-11
CA3152591A1 (en) 2010-03-18
SI2340506T1 (sl) 2016-02-29
DK2340506T3 (en) 2016-02-08
CA3152591C (en) 2023-08-29
GB2478441A (en) 2011-09-07
JP5701212B2 (ja) 2015-04-15
CN104198709A (zh) 2014-12-10
GB201106053D0 (en) 2011-05-25
CN102209968B (zh) 2016-05-04
CA2734535A1 (en) 2010-03-18
HK1204062A1 (en) 2015-11-06
JP2012502281A (ja) 2012-01-26
CA3011730C (en) 2022-05-17
AU2009291811A1 (en) 2010-03-18
AU2015249113A1 (en) 2015-11-12
WO2010030697A1 (en) 2010-03-18

Similar Documents

Publication Publication Date Title
HK1204062A1 (en) Lung cancer biomarkers and uses thereof
IL269454B (en) Qualitative losses and their uses
IL223295A0 (en) Lung cancer biomarkers and uses thereof
EP2227556A4 (en) LUNG CANCER MARKERS AND THEIR USES
GB0719792D0 (en) Cancer biomarkers
EP2443259A4 (en) BIOMARKERS FOR AUTISM AND USES THEREOF
IL202727A0 (en) Covalent diabodies and uses thereof
EP2250287A4 (en) PROOF AND FORECAST OF LUNG CANCER
EP2265642A4 (en) BIOMARKERS
EP2457092A4 (en) CANCER BIOMARKERS AND THEIR USE
EP2263086A4 (en) BIOMARKERS
GB0616230D0 (en) Biomarkers and uses thereof
GB0818660D0 (en) Biomarkers
GB0807214D0 (en) Biomarkers
EP2350917A4 (en) BIOMARKERS OF OVARIAN CANCER AND USES THEREOF
EP2265641A4 (en) BIOMARKERS
GB0821912D0 (en) Biomarkers
GB0818658D0 (en) Biomarkers
GB0720334D0 (en) Cancer biomarker
AU2009900954A0 (en) Cancer Biomarkers and Uses Therefor
GB0805081D0 (en) Biomarkers
GB0805084D0 (en) Biomarkers
GB0809105D0 (en) Biomarkers